Evaluate AbbVie Inc. vs. Pfizer Inc. amidst tariff disputes and drug pricing policies. Click for our comparison of ABBV and ...

The company started demonstrating FCF recovery over the last few quarters and in the above analysis ... in PFE prior to the upcoming earnings release. A 7.5% forward dividend yield is absolutely ...

Be aware that Pfizer is showing 3 possible red flags in our investment analysis and 2 of those ... 27 US stocks that are forecast to pay a dividend yield of over 6% next year.

Pfizer recently made headlines with a strategic collaboration with Guardant Health, aimed at enhancing its oncology portfolio through advanced liquid biopsy technology. Simultaneously, the company ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 6 undervalued ...

While its dividend yield remains attractive at current price levels, Pfizer’s near-term growth ... Twitter @JesseCohenInv for more stock market analysis and insight.

Learn more about whether BioCryst Pharmaceuticals, Inc. or Zai Lab Limited is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

With limited near-term catalysts to offset these pressures, Pfizer’s stock could face further selling pressure post-earnings. While its dividend yield remains attractive at current price levels, ...

With that in mind, let's consider two high-yield dividend stocks worth investing in: Pfizer (NYSE: PFE) and Medical ...

But when a dividend yield reaches ultrahigh levels, investors can feel a heightened level of uncertainty. Wondering if Pfizer ...